229 related articles for article (PubMed ID: 7534227)
1. Gelatinase A activity directly modulates melanoma cell adhesion and spreading.
Ray JM; Stetler-Stevenson WG
EMBO J; 1995 Mar; 14(5):908-17. PubMed ID: 7534227
[TBL] [Abstract][Full Text] [Related]
2. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
3. TIMP-2 expression modulates human melanoma cell adhesion and motility.
Ray JM; Stetler-Stevenson WG
Ann N Y Acad Sci; 1994 Sep; 732():233-47. PubMed ID: 7978796
[TBL] [Abstract][Full Text] [Related]
4. MMP-2: expression, activation and inhibition.
Corcoran ML; Hewitt RE; Kleiner DE; Stetler-Stevenson WG
Enzyme Protein; 1996; 49(1-3):7-19. PubMed ID: 8796994
[TBL] [Abstract][Full Text] [Related]
5. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form.
Stanton H; Gavrilovic J; Atkinson SJ; d'Ortho MP; Yamada KM; Zardi L; Murphy G
J Cell Sci; 1998 Sep; 111 ( Pt 18)():2789-98. PubMed ID: 9718371
[TBL] [Abstract][Full Text] [Related]
6. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells.
Bafetti LM; Young TN; Itoh Y; Stack MS
J Biol Chem; 1998 Jan; 273(1):143-9. PubMed ID: 9417058
[TBL] [Abstract][Full Text] [Related]
7. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.
Kurschat P; Zigrino P; Nischt R; Breitkopf K; Steurer P; Klein CE; Krieg T; Mauch C
J Biol Chem; 1999 Jul; 274(30):21056-62. PubMed ID: 10409657
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
9. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
[TBL] [Abstract][Full Text] [Related]
11. Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
Itoh Y; Ito A; Iwata K; Tanzawa K; Mori Y; Nagase H
J Biol Chem; 1998 Sep; 273(38):24360-7. PubMed ID: 9733724
[TBL] [Abstract][Full Text] [Related]
12. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
[TBL] [Abstract][Full Text] [Related]
13. Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin.
von Bredow DC; Cress AE; Howard EW; Bowden GT; Nagle RB
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):965-72. PubMed ID: 9560329
[TBL] [Abstract][Full Text] [Related]
14. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
15. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
[TBL] [Abstract][Full Text] [Related]
16. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
17. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines.
Liu Z; Ivanoff A; Klominek J
Int J Cancer; 2001 Mar; 91(5):638-43. PubMed ID: 11267973
[TBL] [Abstract][Full Text] [Related]
18. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
[TBL] [Abstract][Full Text] [Related]
19. Activity of ternary gelatinase A-TIMP-2-matrix metallo-proteinase complexes.
Kolkenbrock H; Hecker-Kia A; Orgel D; Ruppitsch W; Ulbrich N
Biol Chem Hoppe Seyler; 1994 Sep; 375(9):589-95. PubMed ID: 7840900
[TBL] [Abstract][Full Text] [Related]
20. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
Kikkawa F
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]